{
    "title": "AstraZeneca counts cost of failed drugs",
    "url": "https://www.dailymail.co.uk/money/news/article-2076807/AstraZeneca-counts-cost-failed-drugs.html",
    "date": "2011-12-20",
    "keywords": [
        "astra",
        "astrazeneca",
        "latestage",
        "hit",
        "research",
        "development",
        "olaparib",
        "blow",
        "failure",
        "drug",
        "treatment",
        "patent",
        "cost",
        "ben",
        "mail",
        "gmt",
        "december",
        "view",
        "news",
        "faller",
        "ftse",
        "yesterday",
        "cancer",
        "disorder",
        "tc5214",
        "cover",
        "cliff",
        "clutch",
        "schizophrenia",
        "seroquel",
        "aid",
        "nexium",
        "attack",
        "generic",
        "copycat",
        "investment",
        "bank",
        "jp",
        "morgan",
        "companys",
        "difficulty",
        "base",
        "joshua",
        "raymond",
        "city",
        "index",
        "disappointment",
        "market",
        "fall",
        "share",
        "price",
        "year",
        "stock",
        "wasnt",
        "company",
        "track",
        "spokesman",
        "challenge",
        "something",
        "number",
        "rd",
        "part",
        "strategy",
        "science",
        "glaxosmithkline",
        "disposal",
        "chunk",
        "consumer",
        "prestige",
        "sale",
        "business",
        "goodys",
        "ecotrin",
        "tagament"
    ],
    "category": [
        "money",
        "news"
    ]
}